P010030/S205: LifeVest Wearable Defibrillator
FDA’s recorded scope: reduction of incoming inspection
Explore this company’s associated devices, FDA decisions and regulatory history.

MedtechLedger currently links 13 FDA records to the applicant name Zoll Manufacturing Corporation. It includes 1 original PMA approval. 2 entries are PMA supplements. 10 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Dec 18, 2001 to Oct 6, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code MVK appears in 13 of the 13 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P010030, with 13 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes. 4 linked filings have a current plain-language explanation checked against the recorded FDA decision.
Applicant mailing address recorded by FDA: 121 Gamma Dr., Pittsburgh, PA, 15238. Recorded on P010030/S205, decision dated Oct 6, 2026.
FDA’s recorded scope: reduction of incoming inspection
P010030/S204 records FDA decision OK30 on October 5, 2026 for Zoll Manufacturing Corporation's LifeVest Wearable Defibrillator. The 30-Day Notice describes removal of an inspection step during manufacturing and servicing. The recorded reason category is a process change involving a manufacturer, sterilizer, packager or supplier. Product code MVK identifies the wearable automated external defibrillator category.
The documented action is removal of a process inspection, rather than a separately described alteration to the wearable device's hardware. The statement does not name the inspection step, specify the manufacturing or servicing stage, or disclose why the step was removed. No validation results or replacement inspection are described. The parent PMA identifier is P010030; a detailed comparison of the old and revised inspection procedures requires information beyond this short notice.
removal of an inspection step performed during manufacturing and servicing
The FDA recorded decision OK30 on 2026-09-29 for PMA supplement P010030/S203, submitted by Zoll Manufacturing Corporation for the LifeVest® Wearable Defibrillator under product code MVK in the Cardiovascular specialty. The supplement is a 30-Day Notice with the recorded reason Process Change - Manufacturer/Sterilizer/Packager/Supplier, and the stated scope is implementation of an alternate finishing process.
This entry concerns a manufacturing process change to an existing approved device rather than a new approval of the LifeVest system, and the source does not identify which component or finishing step is affected. The source also gives no detail on the alternate process, the review basis for OK30, or any conditions attached to the notice, so those points remain unknown from this record.
implementation of an alternate finishing process
The FDA recorded an approval dated 2026-09-09 for P010030/S201, a real-time process supplement submitted by Zoll Manufacturing Corporation under the reason Change Design/Components/Specifications/Material. The listed statement describes approval for an additional battery pack variant for the LifeVest 5100, to be manufactured by a new Tier 1 supplier. The product code is MVK, in the Cardiovascular specialty.
Because the identifier is a supplement to P010030, this action modifies the existing approval rather than approving the LifeVest system anew. The statement does not identify the supplier, the battery pack's specifications or materials, the specific components changed, or any testing, performance data, or clinical evidence. The record also gives no safety or effectiveness finding, so the approval purpose should not be read as independent proof of either.
approval for an additional battery pack variant for the LifeVest 5100 to be manufactured by a new Tier 1 supplier
FDA’s recorded scope: implementation of an automated manufacturing process during electrode belt assembly
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.